Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 377

1.

The human peroxisome proliferator-activated receptor delta gene is a primary target of 1alpha,25-dihydroxyvitamin D3 and its nuclear receptor.

Dunlop TW, Väisänen S, Frank C, Molnár F, Sinkkonen L, Carlberg C.

J Mol Biol. 2005 Jun 3;349(2):248-60. Epub 2005 Apr 7.

PMID:
15890193
2.

Regulation of the human cyclin C gene via multiple vitamin D3-responsive regions in its promoter.

Sinkkonen L, Malinen M, Saavalainen K, Väisänen S, Carlberg C.

Nucleic Acids Res. 2005 Apr 29;33(8):2440-51. Print 2005.

4.

Spatio-temporal activation of chromatin on the human CYP24 gene promoter in the presence of 1alpha,25-Dihydroxyvitamin D3.

Väisänen S, Dunlop TW, Sinkkonen L, Frank C, Carlberg C.

J Mol Biol. 2005 Jul 1;350(1):65-77.

PMID:
15919092
5.

Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.

Seuter S, Pehkonen P, Heikkinen S, Carlberg C.

Biochim Biophys Acta. 2013 Dec;1829(12):1266-75. doi: 10.1016/j.bbagrm.2013.10.003. Epub 2013 Nov 1.

PMID:
24185200
6.

The impact of chromatin organization of vitamin D target genes.

Carlberg C, Dunlop TW.

Anticancer Res. 2006 Jul-Aug;26(4A):2637-45. Review.

7.

Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.

Sertznig P, Dunlop T, Seifert M, Tilgen W, Reichrath J.

Anticancer Res. 2009 Sep;29(9):3647-58.

9.

The 3-epi- and 24-oxo-derivatives of 1alpha,25 dihydroxyvitamin D(3) stimulate transcription through the vitamin D receptor.

Messerlian S, Gao X, St-Arnaud R.

J Steroid Biochem Mol Biol. 2000 Jan-Feb;72(1-2):29-34.

PMID:
10731635
10.

Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor.

Saramäki A, Banwell CM, Campbell MJ, Carlberg C.

Nucleic Acids Res. 2006 Jan 24;34(2):543-54. Print 2006.

11.
12.

Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.

Raval-Pandya M, Freedman LP, Li H, Christakos S.

Mol Endocrinol. 1998 Sep;12(9):1367-79.

PMID:
9731705
13.
14.

Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.

Chow EC, Quach HP, Vieth R, Pang KS.

Am J Physiol Endocrinol Metab. 2013 May 1;304(9):E977-89. doi: 10.1152/ajpendo.00489.2012. Epub 2013 Mar 12.

16.

The vitamin D hormone and its nuclear receptor: molecular actions and disease states.

Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK.

J Endocrinol. 1997 Sep;154 Suppl:S57-73. Review.

17.

VDR primary targets by genome-wide transcriptional profiling.

Goeman F, De Nicola F, D'Onorio De Meo P, Pallocca M, Elmi B, Castrignanò T, Pesole G, Strano S, Blandino G, Fanciulli M, Muti P.

J Steroid Biochem Mol Biol. 2014 Sep;143:348-56. doi: 10.1016/j.jsbmb.2014.03.007. Epub 2014 Apr 13.

PMID:
24726990
19.

Anti-proliferative activity of 25-hydroxyvitamin D3 in human prostate cells.

Munetsuna E, Kawanami R, Nishikawa M, Ikeda S, Nakabayashi S, Yasuda K, Ohta M, Kamakura M, Ikushiro S, Sakaki T.

Mol Cell Endocrinol. 2014 Feb 15;382(2):960-70. doi: 10.1016/j.mce.2013.11.014. Epub 2013 Nov 27.

PMID:
24291609
20.

Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol.

Chow EC, Magomedova L, Quach HP, Patel R, Durk MR, Fan J, Maeng HJ, Irondi K, Anakk S, Moore DD, Cummins CL, Pang KS.

Gastroenterology. 2014 Apr;146(4):1048-59. doi: 10.1053/j.gastro.2013.12.027. Epub 2013 Dec 21.

PMID:
24365583

Supplemental Content

Support Center